<DOC>
	<DOC>NCT00579189</DOC>
	<brief_summary>The purpose of this study is to determine if a topical otic formulation is safe and effective in treating middle ear infections in patients with ear tubes.</brief_summary>
	<brief_title>Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy Tubes</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>6 months to 12 years old Ear tubes in one or both ears Ear drainage visible by the parent / guardian Ear drainage less than 21 days Ear tube may not be silver oxide, silver salt, ttype tube or longshafted tube Patient may not have nontube otorrhea Patient may not have had otic surgery other than tube placement in the last year Patient may not be a menarchal female Diabetic patients are not eligible Patient may not have any disease or condition that would negatively affect the conduct of the study Patient may not require any other systemic antimicrobial therapy during the study. Patient must meet certain medication washouts to be eligible Analgesic use (other than acetaminophen) is not allowed Patient may not be predisposed to neurosensory hearing loss Other protocoldefined inclusion criteria may apply Age Other protocoldefined exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>ear tubes</keyword>
	<keyword>ear drainage</keyword>
	<keyword>ear infection</keyword>
	<keyword>ear drops</keyword>
</DOC>